Merck KGaA (NASDAQ:MKGAY) was upgraded by equities research analysts at Bank of America Corp. from a “neutral” rating to a “buy” rating in a research report issued on Friday.
A number of other research analysts have also weighed in on MKGAY. BMO Capital Markets reissued a “market perform” rating on shares of Merck KGaA in a report on Monday, July 18th. Jefferies Group restated a “hold” rating and issued a $57.00 price target (up from $53.00) on shares of Merck KGaA in a research note on Wednesday, August 10th. Credit Suisse Group AG upgraded Merck KGaA from a “neutral” rating to an “outperform” rating and set a $73.00 price target for the company in a research note on Wednesday, August 10th. Finally, Berenberg Bank downgraded Merck KGaA from a “buy” rating to a “hold” rating in a research note on Friday, August 12th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Merck KGaA has an average rating of “Hold” and a consensus target price of $65.00.
Shares of Merck KGaA (NASDAQ:MKGAY) opened at 35.48 on Friday. The firm has a market capitalization of $46.32 billion and a price-to-earnings ratio of 29.93. Merck KGaA has a 52 week low of $26.91 and a 52 week high of $37.16. The stock has a 50 day moving average price of $35.70 and a 200-day moving average price of $33.76.
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.